Ingevity (NGVT)
(Delayed Data from NYSE)
$45.15 USD
+0.71 (1.60%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $45.14 -0.01 (-0.02%) 6:52 PM ET
3-Hold of 5 3
B Value C Growth F Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
NGVT 45.15 +0.71(1.60%)
Will NGVT be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for NGVT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NGVT
Ingevity (NGVT), Ultrapolymers Tie-Up for Capa Bioplastics Sales
Ingevity (NGVT) Down 12.4% Since Last Earnings Report: Can It Rebound?
NGVT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Hawkins (HWKN) Earnings Lag Estimates in Q4, Revenues Beat
American Vanguard (AVD) Q1 Earnings Beat, Sales Miss Estimates
Innospec's (IOSP) Q1 Earnings Surpass Estimates, Sales Lag
Other News for NGVT
Ingevity announces dates for second-quarter 2024 earnings release and webcast
Ingevity names new general counsel and chief human resources officer to executive leadership team
Ingevity names Ryan Fisher as new general counsel
Ingevity partners with Ultrapolymers Group for European sales of Capa® caprolactone Bioplastics
Ingevity releases 2023 sustainability report, details commitment to actions and product innovations that enable a more sustainable world